Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma
Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma
About this item
Full title
Author / Creator
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Purpose To describe the visual acuity and anatomic outcomes of intravitreal methotrexate (MTX) for the treatment of primary vitreoretinal lymphoma (PVRL). Methods Single-center retrospective case series of patients with a diagnosis of PVRL treated with intravitreal MTX. Patient records were reviewed for demographic information, ocular exam findings...
Alternative Titles
Full title
Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_cb905c3d1d9e4f9dbac2c843e2205625
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cb905c3d1d9e4f9dbac2c843e2205625
Other Identifiers
ISSN
2056-9920
E-ISSN
2056-9920
DOI
10.1186/s40942-021-00346-0
